| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2004 | US20040029879 Viricides for herpes virus |
| 02/12/2004 | US20040029878 Adjust bladder muscle tension |
| 02/12/2004 | US20040029877 Immune response induction; viricides; anticancer agents |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029874 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029872 Administering dopamine antagonist |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/12/2004 | US20040029870 Antiinflammatory agents |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029864 Synergistic mixture of cyclooxygenase inhibitor and active drug |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029861 Using compound containing pyridine ring |
| 02/12/2004 | US20040029860 Anti-proliferative drugs |
| 02/12/2004 | US20040029858 Antitumor agents; solid tumors of rectum, lungs |
| 02/12/2004 | US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents |
| 02/12/2004 | US20040029856 Photodynamic therapy for the treatment of hair loss |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029853 Therapy for gastrointestinal disorders |
| 02/12/2004 | US20040029852 Anticancer agents |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029849 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/12/2004 | US20040029848 Psychological disorders; cognition activators |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029846 Cushing disease; antidepressant; modulate immunology response |
| 02/12/2004 | US20040029845 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 02/12/2004 | US20040029843 Rapidly disintegrating formulations for treating or preventing mucositis |
| 02/12/2004 | US20040029842 Using tetracyclic antibiotic |
| 02/12/2004 | US20040029841 Purinergic antagonists for treating depression |
| 02/12/2004 | US20040029838 Anticancer agents |
| 02/12/2004 | US20040029835 Antitumor agents |
| 02/12/2004 | US20040029833 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/12/2004 | US20040029832 Anticancer agents; angiogenesis inhibitor; side effect reduction |
| 02/12/2004 | US20040029831 Extracts of kava-kava |
| 02/12/2004 | US20040029830 Water-soluble indole-3-propionic acid |
| 02/12/2004 | US20040029829 Bean extract; fermentation |
| 02/12/2004 | US20040029828 Homeostasis-maintaining agents |
| 02/12/2004 | US20040029821 Pharmaceutical composition containing an indolopyrrolocarbazole derivative |
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029817 Water solubility; fungicides |
| 02/12/2004 | US20040029816 Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin |
| 02/12/2004 | US20040029815 Administering complex of glucose and anticancer agents |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029812 Skin disorders; aging resistance |
| 02/12/2004 | US20040029808 Binding antibody to estradiol; test device |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029788 Methods and compositions for the treatment of diseases of the eye |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029783 Prevention, therapy of respiratory system disorders; administering to humans, animals |
| 02/12/2004 | US20040029779 Enzyme replacement therapy; gene therapy; preenzyme moderation of cell surface |
| 02/12/2004 | US20040029777 Pharmaceutical preparation for taste masking |
| 02/12/2004 | US20040029776 Hydroxyethyl starch - containing polypeptide compositions |
| 02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
| 02/12/2004 | US20040029773 Potassium channel moderators |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040029767 Disinfectant |
| 02/12/2004 | US20040029761 O/W emulsion composition and method of preparing the same |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029275 Short interfering RNA (siRNAs); reducing expression by obtaining and introducing into a cell multiple single or double stranded RNAs (dsRNAs) or DNA constructs capable of expressing multiple siRNAs in cells |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029244 Phospholipase d effectors for therapy and screening |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029160 A triplex comprising a hairpin having polypyrimidine sequence linked to a complementary polypurine; targeting single-stranded oligonucleotides and DNA using the hairpins and triplexes |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/12/2004 | US20040028760 Method of treating inflammation and inflammation-related pain |
| 02/12/2004 | US20040028759 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil and sitosterol |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040028756 Platelet-activated factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents |
| 02/12/2004 | US20040028755 Use of CYP2D6 inhibitors in combination therapies |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028750 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028743 Brandycardial agents |
| 02/12/2004 | US20040028741 Oral preparations with favorable disintegration characteristics |
| 02/12/2004 | US20040028740 Transferring to cells; gene therapy; active drug in lipophilic matrix |
| 02/12/2004 | US20040028737 Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| 02/12/2004 | US20040028735 Pharmaceutical formulation |
| 02/12/2004 | US20040028734 Muscular disorders; antiproliferative agents; antiinflammatory agents |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028730 Process for preparing solid dosage forms for unpalatable pharmaceuticals |
| 02/12/2004 | US20040028728 Liposome preparations |
| 02/12/2004 | US20040028726 Transdermal systems for the delivery of clonidine |
| 02/12/2004 | US20040028725 Transdermal delivery of hormones |
| 02/12/2004 | US20040028724 Pharmaceutical preparation of percutaneous absorption type |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028716 Coating a stent with kinase inhibitor |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028702 Muramic acid derivative compounds |
| 02/12/2004 | US20040028691 Administering eicosapentaenoic acid, docosahexaenoic acid |
| 02/12/2004 | US20040028686 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplated organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |